Toxicology and epidemiology of 1,3-butadiene

Critical Reviews in Toxicology

Volumn 27, Issue 1, 1997, Pages

  Himmelstein, Matthew W ^a,c   Acquavella, John F ^b   Recio, Leslie ^a   Medinsky, Michele A ^a   Bond, James A ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b MONSANTO COMPANY   (United States)

^c DUPONT COMPANY   (United States)

Author keywords

1,3 butadiene; epidemiology; polybutadiene; styrene butadiene; toxicology; volatile gas

Indexed keywords

1,3 BUTADIENE; BIOLOGICAL MARKER; BUTADIENE DIEPOXIDE; 1,3 BUTADIENE DERIVATIVE; 1,3-BUTADIENE; CARCINOGEN; MUTAGENIC AGENT;

CARCINOGENICITY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; HUMAN; METABOLITE; MOUSE; MUTAGENICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; RAT; REVIEW; RISK ASSESSMENT; TOXICOKINETICS; XENOBIOTIC METABOLISM; ANIMAL; CANADA; CHEMICALLY INDUCED DISORDER; FEMALE; LEUKEMIA; MALE; OCCUPATIONAL DISEASE; UNITED STATES;

ANIMALIA;

ANIMALS; BIOLOGICAL MARKERS; BUTADIENES; CANADA; CARCINOGENS; FEMALE; HUMANS; LEUKEMIA; MALE; MUTAGENS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; UNITED STATES;

EID: 12644304269     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408449709037482     Document Type: Review

References (230)

1. Acquavella, J. F., The paradox of butadiene epidemiology, Exp. Pathol., 37, 114, 1989.
2. Acquavella, J. F., Delzell, E., and Cole, P., Butadiene and lymphopoietic cancers: the authors reply, Epidemiology, 5, 262, 1994.
3. Adler, I.-D. and Anderson, D., Dominant lethal effects after inhalation exposure to 1,3-butadiene, Mutat. Res., 309, 295, 1994.
4. Adler, I.-D., Cao, J., Filser, J. G., Gassner, P. Kessler, W., Kliesch, U., Neuhäuser-Klaus, A., and Nüsse, M., Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice, Mutat. Res., 309, 307, 1994.
5. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for 1,3-Butadiene, TP-91/07, PB93-110690, U.S. Department of Health and Human Services, 1992.
6. Albertini, R. J., Castle, K. L., and Borcherding, W. R., T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood, Proc. Natl. Acad. Sci. U.S.A., 79, 6617, 1982.
7. Amoore, J. E. and Hautala, E., Odor as an aid to chemical safety: odor thresholds compared with threshold limit values and volatilities for 214 industrial chemicals in air and water dilution, J. Appl. Toxicol., 3, 272, 1983.
8. Andersen, M. E., Physiological modelling of organic compounds, Ann. Occup Hyg., 35, 309, 1991.
9. Andersen, M. E., Clewell, H. J., III, Gargas, M. L., Smith, F. A., and Reitz, R. H., Physiologically based pharmacokinetics and the risk assessment process for methylene chloride, Toxicol. Appl. Pharmacol., 87, 185, 1987.
10. 1 effects in mice exposed to 1,3-butadiene, in Butadiene and Styrene: Assessment of Health Hazards, Sorsa, M., Peltonen, K., Vainio, H., and Hemminki, K., Eds., IARC Scientific Publication 127, Lyon, 1993, 171.
11. Andjelkovich, D., Taulbee, J., Symmons, M., and Williams, T., Mortality of rubber workers with reference to work experience, J. Occup. Med., 19, 397, 1977.
12. Au, W. W., Bechtold, W. E., Whorton, E. B., Jr., and Legator, M. S., Chromosome aberrations and response to g-ray challenge in lymphocytes of workers exposed to 1,3-butadiene, Mutat. Res., 334, 125, 1995.
13. Autio, K., Renzi, L., Catalan, J., Albrecht, O. E., and Sorsa, M., Induction of micronuclei in peripheral blood and bone marrow erythrocytes of rats and mice exposed to 1,3-butadiene by inhalation, Mutat. Res., 309, 315, 1994.
14. Bechtold, W. E., Strunk, M. R., Chang, I.-Y., Ward, J. B., Jr., and Henderson, R. F., Species differences in urinary butadiene metabolites: comparison of metabolite ratios between mice, rats, and humans, Toxicol. Appl. Pharmacol., 127, 44, 1994.
15. Bechtold, W. E., Strunk, M. R., Thornton-Manning, J. R., and Henderson, R. F., Analysis of butadiene, butadiene monoxide, and butadiene dioxide in blood by gas chromatography/gas chromatography/mass spectroscopy, Chem. Res. Toxicol., 8, 182, 1995.
16. Berg, S., Frostling, H., and Jacobsson, S., Chemical analysis of fire gases with gas-chromatography-mass spectrometry, in Proc. Int. Symp. on the Control of Air Pollution in the Work Environment, Part 1, Arbetarskyddsfonden, Stockholm, 1978, 309.
17. Bird, M. G., Future directions - toxicology studies of 1,3-butadiene and isoprene, Environ. Health Perspect., 86, 99, 1990.
18. Birnbaum, L. S., A brief survey of butadiene health effects: a role for metabolic differences, Environ. Health Perspect., 101(Suppl. 6), 161, 1993.
19. Bolt, H. M., Filser, J. G., and Störmer, F., Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats, Arch. Toxicol., 55, 213, 1984.
20. Bolt, H. M., Schmiedel, G., Filser, J. G, Rolzhäuser, H. P., Lieser, K., Wistuba, D., and Schurig, V., Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats, J. Cancer Res. Clin. Oncol., 106, 112, 1983.
21. Bond, J. A., Recio, L., and Andjelkovich, D., Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace, Carcinogenesis, 16, 165, 1995.
22. Bond, J. A., Csanády, G. A., Leavens, T. L., and Medinsky, M. A., Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans, in Butadiene and Styrene: Assessment of Health Hazards, Sorsa, M., Peltonen, K., Vainio, H., and Hemminki, K., Eds., IARC Scientific Publication 127, Lyon, 1993, 45.
23. Bond, G. G., Bodner, K. M., Olsen, G. W., and Cook, R. R., Mortality among workers engaged in the development or manufacture of styrene-based products - an update, Scand. J. Work Environ. Health 18, 145, 1992.
24. Bond, J. A., Martin, O. S., Birnbaum, L. S., Dahl, A. R., Melnick, R. L., and Henderson, R. F., Metabolism of 1,3-butadiene by lung and liver microsomes of rats and mice repeatedly exposed by inhalation to 1,3-butadiene, Toxicol. Lett., 44, 143, 1988.
25. Bond, J. A., Dahl, A. R., Henderson, R. F., and Birnbaum, L. S., Species differences in the distribution of inhaled butadiene in tissues, Am Ind. Hyg. Assoc. J., 48, 867, 1987.
26. Bond, J. A., Dahl, A. R., Henderson, R. F., Dutcher, J. S., Mauderly, J. L., and Birnbaum, L. S., Species differences in the disposition of inhaled butadiene, Toxicol. Appl. Pharmacol., 84, 617, 1986.
27. Boogaard, P. J. and Bond, J. A., The role of hydrolysis in the detoxication of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro, Toxicol. Appl. Pharmacol., 141, 617, 1996.
28. Boogaard, P. J., Sumner, S. C. J., and Bond, J. A., Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro, Toxicol. Appl. Pharmacol., 136, 307, 1996.
29. Brunnemann, K. D., Kagan, M. R., Cox, J. E., and Hoffmann, D., Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection, Carcinogenesis, 11, 1863, 1990.
30. California Air Resource Board (CARB ), Proposed identification of 1,3-butadiene as a toxic air contaminant. Part B. Health assessment. Prepared by the Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, 1992.
31. Carpenter, C. P., Shaffer, C. B., Weil, C. S., and Smyth, H. F., Jr., Studies on the inhalation of 1:3-butadiene; with a comparison of its narcotic effects with benzol, toluol, and styrene, and a note on the elimination of styrene by the human, J. Ind. Hyg. Toxicol., 26, 69, 1944.
32. Checkoway, H., Wilcosky, T., Wolf, P., and Tyroler, H., An evaluation of the associations of leukemia and rubber industry solvent exposures, Am. J. Ind. Med., 5, 239, 1984.
33. Checkoway, H. and Williams, T. M., A hematologic survey of workers at a styrene-butadiene synthetic rubber manufacturing plant. Am. Ind. Hyg. Assoc. J., 43, 164, 1982.
34. Chemical Engineering News, Top 50 chemical production rose modestly last year, Chem. Eng. News, April 11, 12, 1994.
35. Chemical Week, CW product focus: butadiene, Chem. Week, June 15, 56, 1994.
36. Cheng, X. and Ruth, R. A., A simplified methodology for quantitation of butadiene metabolites: application to the study of 1,3-butadiene metabolism by rat liver microsomes, Drug Metab. Dispos., 21, 121, 1993.
37. Choudhary, G., Environmental exposure to 1,3-butadiene: a human health perspective, Environ. Carcinogen. Ecotoxicol. Rev., C12, 23, 1994.
38. Citti, L., Gervasi, P. G., Turchi, G., Bellucci, G., and Bianchini, R., The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in-vitro: synthesis and characterization of the main adducts, Carcinogenesis, 5, 47, 1984.
39. Cochrane, J. E. and Skopek, T. R., Mutagenicity of 1,3-butadiene and its epoxide metabolites. II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice, Carcinogenesis, 15, 719, 1994a.
40. Cochrane, J. E. and Skopek, T. R., Mutagenicity of butadiene and its epoxide metabolites. I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts, Carcinogenesis, 15, 713, 1994b.
41. Colagiovanni, D. B., Stillman, W. S., and Irons, R. D., Chemical suppression of a subpopulation of primitive hematopoietic progenitor cells: 1,3-butadiene produces a hematopoietic defect similar to Steel or White Spotted mutations in mice, Proc. Natl. Acad. Sci. U.S.A., 90, 2803, 1993.
42. Cole, P., Direct testimony before the Occupational Safety and Health Administration, October 1990.
43. Cole, P., Delzell, E., and Acquavella, J., Exposure to butadiene and lymphatic and hematopoietic cancer, Epidemiology, 4, 86, 1993.
44. Cote, I. L. and Bayard, S. P., Cancer risk assessment of 1,3-butadiene, Environ. Health Perspect., 86, 149, 1990.
45. Cowles, S. R., Tsai, S. P., Snyder, P. J., and Ross, C. E., Mortality, morbidity, and haematologic results from a cohort of long term workers involved in 1,3-butadiene monomer production, Occup. Environ. Med., 51, 323, 1994.
46. Crouch, C. N., Pullinger, D. H., and Gaunt, I. F., Inhalation toxicity studies with 1,3-butadiene. II. 3 month toxicity studies in rats. Am. Ind. Hyg. Assoc. J., 40, 796, 1979.
47. Csanády, G. A., Guengerich, F. P., and Bond, J. A., Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice, Carcinogenesis, 13, 1143, 1992.
48. Cunningham, M. J., Choy, W. N., Arce, G. T., Rickard, L. B., Vlachos, D. A., Kinney, L. A., and Sarrif, A. M., In vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats, Mutagenesis, 1, 449, 1986.
49. Dahl, A. R., Sun, J. D., Birnbaum, L. S., Bond, J. A., Griffith, W. C., Jr., Mauderly, J. L., Muggenburg, B. A., Saboruin, P. J., and Henderson, R. F., Toxicokinetics of inhaled 1,3-butadiene in monkeys: comparison to toxicokinetics in rats and mice, Toxicol. Appl. Pharmacol., 110, 9, 1991.
50. Dahl, A. R., Bechtold, W. E., Bond, J. A., Henderson, R. F., Mauderly, J. L., Muggenburg, B. A., Sun, J. D., and Birnbaum, L. S., Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene, Environ. Health Perspect., 86, 65, 1990.
51. Daubert, T. E. and Danner, R. P., Data compilation tables of properties of pure compounds, Am. Inst. Chem. Eng., p. 450, 1985.
52. Davis, C. D., Pirmohamed, M., Kitteringham, N. R., Allott, R. L., Smith, D., and Park, B. K., Kinetic parameters of lymphocyte microsomal epoxide hydrolase in carbamazipine hypersensitive patients: assessment by radiometric HPLC, Biochem. Pharmacol., 50, 1361, 1995.
53. Del Pup, J., Kmiecik, J., Smith, S., and Reitman, F., Improvement in human health risk assessment utilizing site- and chemical-specific information: a case study, in Science and Judgement in Risk Assessment, National Academy Press, New York, 1994, 479.
54. Delzell, E., Sathiakumar, N., Macaluso, M., Hovinga, M., Larson, R., Barbone, F., Beall, C., and Cole, P. A., Follow-up Study of Synthetic Rubber Workers, Final report prepared under contract to International Institute of Synthetic Rubber Producers, October 1995.
55. Delzell, E., Sathiakumar, N., Macaluso, M., Hovinga, M., Larson, R., Barbone, F., Beall, C., and Cole, P. A., Follow-up study of synthetic rubber workers, Toxicology, 113, 182, 1996.
56. de Meester, C., Genotoxic properties of 1,3-butadiene, Mutat. Res., 195, 273, 1988.
57. Deutschmann, S. and Laib, R. J., Concentration-dependent depletion of non-protein sulfhydryl (NPSH) content in lung, heart, and liver tissue of rats and mice after acute inhalation exposure to butadiene, Toxicol. Lett., 45, 175, 1989.
58. Divine, B. J., An update on mortality among workers at a butadiene facility: preliminary results, Environ. Health Perspect., 86, 119, 1990.
59. Divine, B. J., Wendt, J. K., and Hartman, C. M., Cancer mortality among workers at a butadiene production facility, IARC Sci. Publ., 127, 345, 1993.
60. Divine, B. J. and Hartman, C. M., Mortality update of butadiene production workers, Toxicology. 113, 169, 1996.
61. Doerr, J. K., Hooser, S. B., Smith, B. J., and Sipes, I. G., Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: role of diepoxides, Chem. Res. Toxicol., 8, 963, 1995.
62. Downs, T. D., Crane, M. M., and Kim, K. W., Mortality among workers at a butadiene facility, Am. J. Ind. Med., 12, 311, 1987.
63. Downs, T., Pier, S., Crane, M., Yim, K., and Kim, K., Cause-specific mortality in a cohort of 1000 ABS workers. Abstr. Symp. - Butadiene and Styrene: Assessment of Health Hazards. Espoo, Finland, 1992.
64. Duescher, R. J. and Elfarra, A. A., Human liver microsomes are efficient catalysts for 1,3-butadiene oxidation: evidence for major roles by cytochrome P450 2A6 and 2E1, Arch. Biochem. Biophys., 311, 342, 1994.
65. Duescher, R. J. and Elfarra, A. A., Chloroperoxidase-mediated oxidation of 1,3-butadiene to 3-butenal, a crotonaldehyde precursor, Chem. Res. Toxicol., 6, 669, 1993.
66. Duescher, R. J. and Elfarra, A. A., 1,3-Butadiene oxidation by human myeloperoxidase: role of chloride ion in catalysis of divergent pathways, J. Biol. Chem., 267, 19859, 1992.
67. Elfarra, A. A., Sharer, J. E., and Duescher, R. J., Synthesis and characterization of N-acetyl-L-cysteine S-conjugates of butadiene monoxide and their detection and quantitation in urine of rats and mice given butadiene monoxide, Chem. Res. Toxicol., 8, 68, 1995.
68. Elfarra, A. A., Duescher, R. J., and Pasch, C. M., Mechanisms of 1,3-butadiene oxidations to butadiene monoxide and crotonaldehyde by mouse liver microsomes and chloroperoxidase, Arch. Biochem. Biophys., 286, 244, 1991.
69. Elovaara, E., Osterman-Golkar, S., Nakajima, T., Gelboin, H. V., Riihimaki, V., and Sorsa, M., 1,3-Butadiene exposure of rats: hemoglobin adducts of 1,2-epoxybutene and cytochrome P450-related changes in styrene metabolism, in Cytochrome P450, Lechner, M. C., Ed., Libbey Eurotext, Paris, 1994, 567.
70. Environ, Assessment of the Potential Risks to Workers from Exposure to 1,3-Butadiene. Chemical Manufacturers Association, Washington, D.C., 1986.
71. European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), No. 4, 1,3-Butadiene Criteria Document, Avenue E, Van Nieuwenhuyse 4, B. 6, B-1160 Brussels, Belgium, 1993.
72. Evelo, C. T. A., Oostendorp, J. G. M., ten Berge, W. F., and Borm, J. A., Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses, Environ. Health Perspect., 101, 496, 1993.
73. Fajen, J. M., Roberts, D. R., Ungers, L. J., and Krishnan, E. R., Occupational exposure of workers to 1,3-butadiene, Environ. Health Perspect., 86, 11, 1990.
74. Fajen, J. M., Lunsford, R. A., and Roberts, D. R., Industrial exposure to 1,3-butadiene in monomer, polymer, and end user industries, in Butadiene and Styrene: Assessment of Health Hazards, Sorsa, M., Peltonen, K., Vainio, H., and Hemminki, K., Eds., IARC Scientific Publication 127, Lyon, 1993, 3.
75. Filser, J. G. and Bolt, H. M., Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats, Arch. Toxicol., 55, 219, 1984.
76. Freeman, J. E., Stirling, D. A., Russell, A. L., and Wolf, C. R., cDNA sequence, deduced amino acid sequence, predicted gene structure and chemical regulation of CYP2E1, Biochem. J., 281, 689, 1992.
77. Gardner, M. J., Osmond, C., Pannett, B., and Acheson, E. D., Reply to Letter to the Editor, Lancet, 1, 437, 1986.
78. Gargas, M. L., Medinsky, M. A., and Andersen, M. E., Pharmacokinetic modeling for describing the uptake, systemic distribution, and disposition of inhaled chemicals, Crit. Rev. Toxicol., 25, 237, 1995.
79. Gay, P. and Contamine, D., Study of the ref(2)P lous of Drosophila melanogaster, Mol. Gen. Genet., 239, 361, 1993.
80. 1 mouse tumors induced by exposure to 1,3-butadiene, Cancer Res., 50, 4818, 1990.
81. Goodrow, T. L., Nichols, W. W., Storer, R. D., Anderson, M. W., and Maronpot, R. R., Activation of H-ras is prevelant in 1,3-butadiene-induced and spontaneously occurring murine Harderian gland tumors, Cancer Res., 55, 2665, 1994.
82. Grossman, E. A. and Martonik, J., OSHA's approach to risk assessment for setting a revised occupational exposure standard for 1,3-butadiene, Environ. Health Perspect., 86, 155, 1990.
83. Hackett, P. L., Brown, M. G., Clark, M. L., Evanoff, J. J., Rowe, S. E., McClananhan, B. J., Buschbom, R. L., Decker, J. R., Rommereim, R. L., and Westerberg, R. B., Sperm-head morphology study in B6C3F1 mice following inhalation exposure to 1,3-butadiene, Prepared for the National Institute of Environmental Health Sciences, National Toxicology Program, Pacific Northwest Laboratory, Battelle Memorial Institute, Final Technical Report No. NIH-Y01-ES-70153, Richland, WA, unpublished, 1988a.
84. Hackett, P. L., Mast, T. J., Brown, M. G., Clark, M. L., Evanoff, J. J., Rowe, S. E., McClananhan, B. J., Buschbom, R. L., Decker, J. R., Rommereim, R. L., and Westerberg, R. B., Dominant lethal study in CD-1 mice following inhalation exposure to 1,3-butadiene, Prepared for the National Institute of Environmental Health Sciences, National Toxicology Program, Pacific Northwest Laboratory, Battelle Memorial Institute, Final Technical Report No. NIH-Y01-ES-70153, Richland, WA, unpublished, 1988b.
85. Hackett, P. L., Sikov, M. R., Mast, T. J., Brown, M. G., Buschbom, R. L., Clark, M. L., Decker, J. R., Evanoff, J. J., Rommereim, R. L., Rowe, S. E., and Westerberg, R. B., Inhalation developmental toxicology studies of 1,3-butadiene in the rat, Prepared for the National Institute of Environmental Health Sciences, National Toxicology Program, Pacific Northwest Laboratory, Battelle Memorial Institute, Final Report No. NIH-401-ES-40131, Richland, WA, unpublished, 1987a.
86. Hackett, P. K., Sikov, M. R., Mast, T. J., Brown, M. G., Buschbom, R. L., Clark, M. L., Decker, J. R., Evanoff, J. J., Rommereim, R. L., Rowe, S. E., and Westerberg, R. B., Inhalation developmental toxicology studies: teratology study of 1,3-butadiene in mice, Prepared for the National Institute of Environmental Health Sciences, National Toxicology Program, Pacific Northwest Laboratory, Battelle Memorial Institute, Final Report No. NIH-401-ES-40131, Richland, WA, unpublished, 1987b.
87. Hallenbeck, W. H., Cancer risk assessment for the inhalation of 1,3-butadiene using physiologically based pharmacokinetic modeling (PBPK), Bull. Toxicol., 49, 66, 1992.
88. Hansch, C. and Leo, A. J., Medchem project. Issue No. 26. Pomona College, Claremont, CA, 1985.
89. Hassett, C., Aicher, L., Sidhu, J. S., and Omiecinski, C. J., Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants, Hum. Mol. Genet., 3, 421, 1994.
90. Hattis, D., and Wasson, J., A pharmacokinetic/mechanism-based analysis of the carcinogenic risk of butadiene, Report CTPID 87-3, Center of Technology Policy and Industrial Development, Massachusetts Institute of Technology, Cambridge, MA, 1987.
91. Hayes, R. B., Xi, L., Bechtold, W. E., Rothman, N., Yao, M., Henderson, R., Zhang, L., Smith, M. T., Zhang, D., Wiemels, J., Dosemeci, M., Yin, S., and O'Neill, J. P., hprt Mutation frequency among workers exposed to 1,3-butadiene in China, Toxicology, in press, 1996.
92. Health Effects Institute (HEI), Research priorities for mobile air toxics: research priorities to reduce uncertainities for 1,3-butadiene, Health Effects Inst. Commun., 2, 44, 1993.
93. Himmelstein, M. W., Turner, M. J., Asgharian, B., and Bond, J. A., Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation, Carcinogenesis, 15, 1479, 1994.
94. Himmelstein, M. W., Asgharian, B., and Bond, J. A., High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene, Toxicol. Appl. Toxicol., 132, 281, 1995.
95. Hine, J. and Mookerjee, P. K., The intrinsic hydrophilic character of organic compounds. Correlations in terms of structural contributions, J. Org. Chem., 40, 292, 1975.
96. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., and Vainio, H., The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung, Carcinogenesis, 14, 1479, 1993.
97. Huff, J. E., Melnick, R. L., Solleveld, H. A., Haseman, J. K., Powers, M., and Miller, R. A., Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure, Science, 227, 548, 1985.
98. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 39, 1,3-Butadiene, World Health Organization, Lyon, France, 1986, 155.
99. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 54, Occupational Exposures to Mists and Vapors from Strong Inorganic Acids; and Other Industrial Chemicals, World Health Organization, Lyon, France, 1992.
100. ICF/Clement, Characterization of risks associated with occupational exposure to 1,3-butadiene, final report, OSHA, U.S. Department of Labor, Washington, D.C., 1986.
101. International Institute of Synthetic Rubber Producers (IISRP), The Toxicity and Carcinogenicity of Butadiene Gas Administered to Rats by Inhalation for Approximately 24 Months, Report No. 2653-522/2, International Institute of Synthetic Rubber Products, Houston, TX, 1981a.
102. International Institute of Synthetic Rubber Producers (IISRP), 1,3-Butadiene: Inhalation Teratogenicity Study in the Rat, Report No. 2788-522/3, International Institute of Synthetic Rubber Products, Houston, TX, 1981b.
103. Irons, R. D., Le, A. T., Som, D. B., and Stillman, W. S., 2′,3′-Dideoxycytidine-induced thymic lymphoma correlates with species-specific suppression of a subpopulation of primitive hematopoietic progenitor cells in mouse but not rat or human bone marrow, J. Clin. Invest., 95, 2777, 1995.
104. Irons, R. D., Colagiovanni, D. B., and Stillman, W. S., Murine thymic lymphoma is associated with a species-specific hematopoietic progenitor cell population, Toxicology, in press, 1996.
105. Irons, R. D., Smith, C. N., Stillman, W. S., Shah, R. S., Steinhagen, W. H., and Leiderman, L. J., Macrocytic-megaloblastic anemia in male B6C3F1 mice following chronic exposure to 1,3-butadiene, Toxicol. Appl. Pharmacol., 83, 95, 1986a.
106. Irons, R. D., Smith, C. N., Stillman, W. S., Shah, R. S., Steinhagen, W. H., and Leiderman, L. J., Macrocytic-megaloblastic anemia in male NIH Swiss mice following repeated exposure to 1,3-butadiene, Toxicol. Appl. Pharmacol., 85, 450, 1986b.
107. Irons, R. D., Stillman, W. S., and Cloyd, M. W., Selective activation of endogenous ecotropic retrovirus in hematopoietic tissues of B6C3F1 mice during the preleukemic phase of 1,3-butadiene exposure, Virology, 161, 457, 1987.
108. Irons, R. D., Cathro, H. P., Stillman, W. S., Steinhagen, W. H., and Shah, R. S., Susceptibility to 1,3-butadiene-induced leukemogenesis correlated with endogenous ecotropic retroviral background in the mouse, Toxicol. Appl. Pharmacol., 191, 170, 1989.
109. Irvine, L. F. H., 1,3-Butadiene: inhalation teratogenicity study in the rat, Final Report, Hazleton Laboratories Europe Ltd., Harrogate, England, OTS Submission, Microfiche No. 050 545, 1981.
110. Jauhar, P. P., Henika, P. R., MacGregor, J. T., Wehr, C. M., Shelby, M. D., Murphy, S. A., and Margolin, B. H., 1,3-Butadiene: induction of micronucleated erythrocytes in the peripheral blood of B6C3F1 mice exposed by inhalation for 13 weeks, Mutat. Res., 209, 171, 1988.
111. Johanson, G. and Filser, J. G., A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation, Arch. Toxicol., 67, 151, 1993.
112. Kelsey, K. T., Christiani, D. C., and Wiencke, J. K., Bimodal distribution of sensitivity to SCE induction by diepoxybutane in human lymphocytes. II. Relationship to baseline SCE frequency, Mutat. Res., 248, 27, 1991.
113. Kirshenbaum, I., Butadiene, in Encyclopedia of Chemical Technology, Vol. 4, 3rd ed., Stannden, A. and Kirk-Othmer, Eds., John Wiley & Sons, New York, 1978, 313.
114. Kohn, M. C. and Melnick, R. L., Species differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control, Carcinogenesis, 14, 619, 1993.
115. 14C] 1,3-butadiene, Toxicol. Lett., 30, 131, 1986a.
116. Kreiling, R., Laib, R. J., Filser, J. G., and Bolt, H. M., Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokientics, Arch. Toxicol., 58, 235, 1986b.
117. Kreiling, R., Laib, R. J., Filser, J. G., and Bolt, H. M., Inhalation pharmacokinetics of 1,2-epoxy-butene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis, Arch. Toxicol., 61, 7, 1987.
118. Kreiling, R., Laib, R. J., and Bolt, H. M., Depletion of hepatic non-protein sulfhydryl content during exposure of rats and mice to butadiene, Toxicol. Lett., 41, 209, 1988.
119. Kreuzer, P. E., Kessler, W., Welter, H. F., Baur, C., and Filser, J. G., Enzyme specific kinetics of 1,2-epoxybutene-3 in microsomes and cytosol from livers of mouse, rat, and man, Arch. Toxicol., 65, 59, 1991.
120. Krishnan, K. and Andersen, M. E., Physiolgically based pharmacokinetic modeling in toxicology, in Principles and Methods of Toxicology, Hayes, A. W., Ed., Raven Press, New York, 1994, 149.
121. Kroschwitz, J. I. and Howe-Grant, M., Butadiene, in Encyclopedia of Chemical Technology, Vol. 4, 4th ed., Stannden, A. and Kirk-Othmer, Eds., John Wiley & Sons, New York, 1992, 663.
122. Laib, R. J., Filser, J. G., Kreiling, R., Vangala, R. R., and Bolt, H. M., Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice, Environ. Health Perspect., 86, 57, 1990.
123. Landrigan, P. J., Critical assessment of epidemiologic studies on the human carcinogenicity of 1,3-butadiene, Environ. Health Perspect., 86, 143, 1990.
124. Landrigan, P. J., Critical assessment of epidemiologic studies on the human carcinogenicity of 1,3-butadiene and styrene, in Butadiene and Styrene: Assessment of Health Hazards, Sorsa, M., Peltonen, K., Vainio, H., and Hemminki, K., Eds., IARC Scientific Publication 127, Lyon, 1993, 375.
125. Lawley, P. D. and Brooks, P., Further studies on the alkylation of nucleic acids and their constituent nucleotides, Biochem. J., 89, 127, 1963.
126. Lawley, P. D. and Brooks, P., Interstrand cross-linking of DNA by difunctional alkylating agents, J. Mol. Biol., 25, 143, 1967.
127. Leiderman, L. J., Stillman, W. S., Shah, R. S., Steinhagen, W. H., and Irons, R. D., Altered hematopoietic stem cell development in male B6C3F1 mice following exposure to 1,3-butadiene, Exp. Mol. Pathol., 44, 50, 1986.
128. 32P-postlabelling of DNA adducts formed after exposure to epoxybutane and diepoxybutane, in Postlabelling Methods for Detection of DNA Adducts, Phillips, D. H., Castegnaro, M., and Bartsch, H., Eds., IARC Scientific Publications 124, Lyon, 1993, 277.
129. Li, C. Y., Yandell, D. W., and Little, J. B., Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in-vitro. Somatic Cell and Mol. Genet., 18, 77, 1992.
130. Lichtenberg, G., Nowak, C., Gleier, K., Meckert, C., and Richter-Reichhelm, R.-B., Anchorage independent colony growth of fetal hamster lung epithelial cells after treatment with diepoxybutane, Toxicol. Lett., 75, 193, 1995.
131. Lide, D. R., CRC Handbook of Chemistry and Physics, Frederikse, H. P. R., Ed., 75th ed., CRC Press, Boca Raton, FL, 1994, 1625.
132. Löfroth, G., Burton, R. M., Forehand, L., Hammond, S. K., Sella, R. L., Zweidinger, R. B., and Lewtas, J., Characterization of environmental tobacco smoke, Environ. Sci. Technol., 23, 610, 1989.
133. Lyman, W. J., Reehl, W. F., and Rosenblatt, D. H., Handbook of Chemical Property Estimation Methods, McGraw-Hill, New York, chap. 4, 5, and 15, 1982.
134. Malvoisin, E., Lhoest, G., Poncelet, F., Roberfroid, M., and Mercier, M., Identification and quantitation of 1,2-epoxybutene-3 as the primary metabolite of 1,3-butadiene, J. Chromatogr., 178, 419, 1979a.
135. Malvoisin, E., Evrard, E., Roberfroid, M., and Mercier, M., Determination of Kováts retention indices with a capillary column and electron capture detection: application to the assay of the enzymatic conversion of 3,4-epoxy-1-butene into diepoxybutane, J. Chromatogr., 179, 81, 1979b.
136. Malvoisin, E. and Roberfroid, M., Hepatic microsomal metabolism of 1,3-butadiene, Xenobiotica, 12, 137, 1982.
137. Maniglier-Poulet, C., Cheng, X., Ruth, J. A., and Ross, D., Metabolism of 1,3-butadiene to butadiene monoxide in mouse and human bone marrow cells, Chem. Biol. Int., 97, 119, 1995.
138. Matanoski, G. M. and Santos-Burgoa, C., Butadiene and lymphatic and hematopoietic cancer (Letter to the Editor), Epidemiology, 5, 261, 1994.
139. Matanoski, G. M., Santos-Burgoa, C., Zeger, S., and Schwartz, L., Nested case control study of lymphopoietic cancers in workers of the styrene-butadiene polymer manufacturing industry, Final report prepared under contract to International Institute of Synthetic Rubber Producers, April 1989.
140. Matanoski, G. M., Santos-Burgoa, C., and Schwartz, L., Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry 1943-1982, Final report prepared under contract to International Institute of Synthetic Rubber Producers, April 1988.
141. Matanoski G. M. and Schwartz, L., Mortality of workers in styrene-butadiene polymer production, J. Occup. Med., 29, 675, 1987.
142. Matanoski, G. M., Santos-Burgoa, C., and Schwartz, L., Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry, Environ. Health Perspect., 86, 107, 1990.
143. McAuliffe, C., Solubility in water of paraffin, cycloparaffin, olefin, acetylene, cycloolefin and aromatic hydrocarbons, J. Phys. Chem., 70, 1267, 1966.
144. McGraw, J., Supplemental Written Testimony to the Occupational Safety and Health Administration - Part B. Time Weighted Average Exposure Data. Part C. "Short-term" Exposure Data, November 1990.
145. McMichael, A. J., Spirtas, R., Gamble, J. F., and Tousey, P. M., Mortality among rubber workers: relationship to specific jobs, J. Occup. Med., 18, 178, 1976.
146. MCA, Chemical safety data sheet SD-55, Properties and essential information for safe handling and use of butadiene, Manufacturing Chemists Association, Washington, D.C., 1974.
147. Medinsky, M. A., Leavens, T. L., Csanády, G. A., Gargas, M. L., and Bond, J. A., In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data, Carcinogenesis, 15, 1329, 1994.
148. Medinsky, M. A. and Klaassen, C. D., Toxicokinetics, in Casarette and Doull's Toxicology, The Basic Science of Poisons, 5th ed., Klaassen, C. D., Ed., McGraw-Hill, New York, 187.
149. Meinhardt, T. J., Lemen, R. A., Crandall, M. S., and Young, R. J., Environmental epidemiologic investigations of the styrene-butadiene rubber industry, Scand. J. Work Environ. Health, 8, 250, 1982.
150. Melnick, R. L., Huff, J. E., Haseman, J. K., and McConnell, E. E., Chronic toxicity results and ongoing studies of 1,3-butadiene by the National Toxicology Program, Ann. N.Y. Acad. Sci., 534, 648, 1988.
151. Melnick, R., Huff, J., and Miller, R., Toxicology and carcinogenicity of 1,3-butadiene, in Assessment of Inhalation Hazards: Integration and Extrapolation Using Diverse Data, Mohn, U., Ed., Springer-Verlag, New York, 1989, 177.
152. Melnick, R. L., Huff, J. E., Bird, M. G., and Acquavella, J. A., Symposium overview: toxicology, carcinogenesis, and human health aspects of 1,3-butadiene, Environ. Health Perspect., 86, 3, 1990a.
153. Melnick, R. L., Huff, J., Chou, B. J., and Miller, R. A., Carcinogenicity of 1,3-butadiene in C57B1/6 × C3HF1 mice at low exposure concentrations, Cancer Res., 50, 6592, 1990b.
154. The Merck Index, An Encyclopedia of Chemicals, Drugs, and Biologicals, 11th ed., Budavari, S., Ed., Merck and Co., Rahway, NJ, 1989, 230.
155. Miettinen, O. S., Theoretical Epidemiology, John Wiley & Sons, New York, 1985.
156. Miller, L. M., Investigation of selected potential environmental contaminants: butadiene and its oligomers, Franklin Research Center, Philadelphia, PA, EPA 560/ 2-78-008, 1978.
157. Morrissey, R. E., Schwetz, B. A., Hackett, P. L., Sikov, M. R., Hardin, B. D., McClanahan, B. J., Decker, J. R., and Mast, T. J., Overview of reproductive and developmental toxicity studies of 1,3-butadiene in rodents, Environ. Health Perspect., 86, 79, 1990.
158. National Research Council (NRC), Science and Judgement in Risk Assessment, National Academy Press, Washington, D.C., 1994.
159. National Toxicology Program (NTP), Toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhalation studies), NTP TR No. 288, 1-111, Research Triangle Park, NC, 1984.
160. National Toxicology Program (NTP), NTP Technical Report on the Toxicology and Carcinogenesis studies of 1,3-Butadiene, NTP TR 434, No. 93-3165, 1-391, Research Triangle Park, NC, 1993.
161. 13C]butadiene, Chem. Res. Toxicol., 9, 764, 1996.
162. Neagu, I., Koivisto, P., Neagu, C., Kostiainen, R., Stenby, K., and Peltonen, K., Butadiene monoxide and deoxyguanosine alkylation products at the N7-position, Carcinogenesis, 16, 1809, 1995.
163. Neligan, R. E., Hydrocarbons in the Los Angeles atmosphere, Arch. Environ. Health, 5, 581, 1962.
164. NIOSH, A quantitative assessment of the risk of cancer associated with
165. Nicklas, J. A., O'Neill, J. P., and Albertini, R. J., Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymophocytes, Mutat. Res., 173, 65, 1986.
166. Norppa, H., Hirvonen, A., Järventaus, H., Uusküla, M., Tasa, G., Ojajärvi, A., and Sorsa, M., Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange by diepoxybutane in cultured human lymphocytes, Carcinogenesis, 16, 1261, 1995.
167. Occupational Safety and Health Administration, Occupational Exposure to 1,3 butadiene: proposed rule, Fed. Regist., 55, 32747, August 10, 1990.
168. Osterman-Golkar, S. M., Bond, J. A., Ward, J. B., and Legator, M. S., Use of haemoglobin adducts for biomonitoring exposure to 1,3-butadiene, in Butadiene and Styrene: Assessment of Health Hazards, Sorsa, M., Peltonen, K., Vainio, H., and Hemminki, K., Eds., IARC Scientific Publication 127, Lyon, 1993, 124.
169. Osterman-Golkar, S. M., Kautiainen, A., Bergmark, E., Håkansson, K., and Måki-Paakkanen, J., Hemoglobin adducts and urinary mercapturic acids in rats as biological indictors of butadiene exposure, Chem.-Biol. Interact., 80, 291, 1991.
170. Ott, M. G., Assessment of 1,3-butadiene epidemiology studies, Environ. Health Perspect., 86, 135, 1990.
171. Owen, P. E. and Glaister, J. R., Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats, Environ. Health Perspect., 86, 19, 1990.
172. Owen, P. E. Glaister, J. R., Gaunt, I. F., and Pullinger, D.H., Inhalation toxicity studies with 1,3-butadiene. III. Two year toxicity/carcinogencity study in rats, Am. Ind. Hyg. Assoc. J., 48, 407, 1987.
173. Peltonen, K., Koivisto, P., Neagu, I., Kostianinen, R., Kilpeläinen, I., and Sorsa, M., Estimating internal dose of 1,3-butadiene: preliminary data on use of modified purine bases as markers of exposure, in Butadiene and Styrene: Assessment of Health Hazards, Sorsa, M., Peltonen, K., Vainio, H., and Hemminki, K., Eds., IARC Scientific Publications 127, Lyon, France, 1993, 119.
174. Pelz, N., Dempster, A. M., and Shore, P. R., Analysis of low molecular weight hydrocarbons including 1,3-butadiene in engine exhaust gases using an aluminum oxide porous-layer open-tubular fused-silica column, J. Chromatogr. Sci., 28, 238, 1990.
175. Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., and Taylor, J. B., Human glutathione S-transferase J (GSTT1): cDNA cloning and characterization of a genetic polymorphism, Biochem. J., 300, 271, 1994.
176. Ramsey, J. C. and Andersen, M. E., A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans, Toxicol. Appl. Pharmacol., 73, 159, 1984.
177. Reardon, J. T., Liljestrand-Golden, C. A., Dusenberry, R. L., and Smith, P. D., Molecular analysis of diepoxybutane-induced deletions at the rosy locus of Drosophila melanogaster, Genetics, 115, 323, 1987.
178. Recio, L. and Meyer, K., Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lac1 transgenic mice exposed to 1,3-butadiene, Environ. Mol. Mutagen., in press.
179. Recio, L., Cochrane, J., Simpson, D., Skopek, T. R., O'Neill, J. P., Nicklas, J. A., and Albertini, R. J., DNA sequence analysis of in vivo hprt mutation in human T-lymphocytes, Mutagenesis, 5, 505, 1990.
180. Recio, L., Osterman-Golkar, S., Csanády, G. A., Turner, M. J., Myhr, B., Moss, O., and Bond, J. A., Determination of mutagenicity in tissues of transgenic mice following exposure to 1,3-butadiene and N-ethyl-N-nitrosourea, Toxicol. Appl. Pharmacol., 117, 58, 1992.
181. Rodger, R. S., Fletcher, K., Fail, B. J., Rahman, H., Sviland, L., and Hamilton, P. J., Factors influences haematological measurements in healthy adults, J. Chron. Dis., 40, 943, 1977.
182. Rothman, K. J., Modern Epidemiology, Little, Brown, Boston, 1986.
183. Sabourin, P. J., Burka, L. T., Bechtold, W. E., Dahl, A. R., Hoover, M. D., Chang, I.-Y., and Henderson, R. F., Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetyl-cysteinyl)butane, a novel metabolite of butadiene, Carcinogenesis, 13, 1633, 1992.
184. Santos-Burgoa, C., Matanoski, G. M., Zeger, S., and Schwartz, L., Lympho-hematopoietic cancer in styrene-butadiene polymerization workers, Am. J. Epidemiol., 136, 843, 1992.
185. Sasiadek, M., Järentaus, H., and Sorsa, M., Sister-chromatid exchanges induced by 1,3-butadiene and its epoxides in CHO cells, Mutat. Res., 263, 47, 1991a.
186. Sasiadek, M., Norppa, H., and Sorsa, M., 1,3-Butadiene and its epoxides induce sister-chromatid exchanges in human lymphocytes in-vitro, Mutat. Res., 261, 117, 1991b.
187. Sax, N. I. and Lewis, R. J., Hawley's Condensed Chemical Dictionary, 11th ed., Van Nostrand Reinhold, New York, 1987, 177.
188. Schmidt, U. and Loeser, E., Species differences in the formation of butadiene monoxide from 1,3-butadiene, Arch. Toxicol., 57, 222, 1985.
189. Seaton, M. J., Follansbee, M. H., and Bond, J. A., Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochrome P450 2E1 and 3A4 and human, mouse and rat liver microsomes, Carcinogenesis, 16, 2287, 1995.
190. 7-guanosine adducts of butadiene monoxide, Chem. Res. Toxicol., 9, 126, 1996.
191. Sharer, J. E., Duescher, R. J., and Elfarra, A. A., Formation, stability, and rearrangements of the glutathione conjugates of butadiene monoxide: evidence for the formation of stable sulfurane intermediates, Chem. Res. Toxicol., 4, 430, 1991.
192. Sharer, J. E., Duescher, R. J., and Elfarra, A. A., Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the glutathione conjugation of butadiene monoxide in mice and rats: possible role in 1,3-butadiene-induced toxicity, Drug Metab. Dispos., 20, 658, 1992.
193. Sharer, J. E. and Elfarra, A. A., S-(2-hydroxy-3-buten-1-yl)glutathione and S-(1-hydroxy-3-buten-2-yl)glutathione are in vivo metabolites of 1,3-butadiene monoxide: detection and quantitation in bile, Chem. Res. Toxicol., 5, 787, 1992.
194. Shugaev, B. B., Concentrations of hydrocarbons in tissues as a measure of toxicity, Arch. Environ. Health, 18, 878, 1969.
195. Singer, B. and Grunberger, D., Molecular Biology of Mutagens & Carcinogens, Plenum Press, New York, 1983.
196. Sisk, S. C., Pluta, L. J., Bond, J. A., and Recio, L., Molecular analysis of lac1 mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene, Carcinogenesis, 15, 471, 1994.
197. Sorsa, M., Autio, K., Demopoulos, N. A., Järventaus, H., Rössner, P., Srám, R. J., Stephanou, G., and Vlachodimitropoulos, D., Human cytogenetic bio-monitoring of occupational exposure to 1,3-butadiene, Mutat. Res., 309, 321, 1994.
198. St.-Pierre, M. V. and Pang, K. S., Kinetics of sequential metabolism. I. Formation and metabolism of oxazepam from nordiazepam and temazepam in the perfused murine liver, J. Pharmacol. Exp. Ther., 265, 1429, 1993.
199. Stewart, P. A., Schairer, C., and Blair, A., Comparison of jobs, exposures, and mortality risks for short-term and long-term workers, J. Occup. Med., 32, 703, 1990.
200. Tates, A. D., van Dam, F. J., de Zwart, F. A., van Teylingen, C. M. M., and Natarajan, A.T., Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene, Mutat. Res., 309, 299, 1994.
201. Thier, R., Müller, M., Taylor, J. B., Pemble, S. E., Ketterer, B., and Guengerich, F. P., Enhancement of bacterial mutagenicity of bifunctional alkylating agents by expression of mammalian glutathione S-transferase, Chem. Res. Toxicol., 8, 465, 1995.
202. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C., Jr., and Henderson, R. F., Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene, Carcinogenesis, 16, 1723, 1995a.
203. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C., Jr., Pei, L., and Henderson, R. F., Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low-level inhalation exposure, Carcinogenesis, 16, 2875, 1995b.
204. Thurmond, L. M., Lauer, L. D., House, R. V., Stillman, W. S., Irons, R. D., Steinhagen, W. H., and Dean, J. H., Effect of short-term inhalation exposure to 1,3-butadiene on murine immune functions, Toxicol. Appl. Pharmacol., 86, 170, 1986.
205. Tice, R. R. and Ivett, J. L., Cytogenetic analysis of bone marrow, in Toxicology of the Blood and Bone Marrow, Irons, R. D., Ed., Raven Press, New York, 1985.
206. Tice, R. R., Boucher, R., Luke, C. A., and Shelby, M. D., Comparative cytogenetic analysis of bone marrow damage induced in male B6C3F1 mice by multiple exposures to gaseous 1,3-butadiene, Environ. Mutagen., 9, 235, 1987.
207. Turnbull, D., Rodricks, J. V., and Brett, S. M., Assessment of the potential risk to workers from exposure to 1,3-butadiene, Environ. Health Perspect., 86, 159, 1990.
208. U.S. Environmental Protection Agency (EPA), Cancer Risk from Outdoor Exposure to Air Toxics, Vol. 2, Appendices (EPA-450/1-90-004b), Washington, D.C., 1990.
209. U.S. Environmental Protection Agency (EPA), Non-methane Organic Compound Monitoring Program (Final Report 1988), Vol. 2, Urban Air Toxics Monitoring Program (PB90-146697), Washington, D.C., 1989.
210. U.S. Environmental Protection Agency (EPA), Mutagenicity and Carcinogenicity Assessment of 1,3-Butadiene, Office of Health and Environmental Assessment, Office of Research and Development, Washington, D.C., 1985a.
211. U.S. Environmental Protection Agency (EPA), Assessment of 1,3-butadiene as a potentially toxic air pollutant, Fed. Regist., 50(197), 41466, 1985b.
212. Uusküla, M., Järventaus, H., Hirvonen, A., Sorsa, M., and Norppa, H., Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocytes, Carcinogenesis, 16, 947, 1995.
213. Van Duuren, B. L., Nelson, N., Orris, L., Palmes, E. D., and Schmitt, F. L., Carcinogenicity of epoxides, lactones, and peroxy compounds, J. Natl. Cancer Inst., 31, 41, 1963.
214. Van Duuren, B. L., Langoeth, L., Orris, L., Teebor, G., Nelson, N., and Kuschner, M., Carcinogenicity of epoxides, lactones, and peroxy compounds. IV. Tumor response in epithelial and connective tissue in mice and rats, J. Natl. Cancer Inst., 37, 825, 1966.
215. Vangala, R. R., Laib, R. J., and Bolt, H. M., Evaluation of DNA damage by alakaline elution technique after inhalation exposure of rats and mice to 1,3-butadiene, Arch. Toxicol., 67, 34, 1993.
216. Van Sittert, J. and Van Vliet, E. W. N., Monitoring occupational exposure to some industrial chemicals by determining hemoglobin adducts, Clin. Chem., 40, 1472, 1994.
217. Verschueren, K., Handbook of Environmental Data on Organic Chemicals, Van Nostrand Reinhold, New York, 1983, 296.
218. Ward, E. M., Fajen, J. M., Ruder, A., Rinsky, R. A., Halperin, W. E., and Fessler-Flesch, C. A., Mortality study of workers in 1,3-butadiene production units identified from a chemical workers cohort, Environ. Health Perspect., 103, 598, 1995.
219. Ward, J. B., Jr., Ammenheuser, M. M., Whorton, E. B., Jr., Bechtold, W. E., Kelsey, K. T., and Legator, M. S., Biological monitoring for mutagenic effects of occupational exposure to butadiene, Toxicology, 113, 157, 1996.
220. Ward, J. B., Jr., Ammenheuser, M. M., Bechtold, W. E., Whorton, E. B., Jr., and Legator, M. S., hprt Mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant, Environ. Health Perspect., 102, 79, 1994.
221. Weast, R. C., Astle, M. J., and Beyer, W. H., CRC Handbook of Chemistry and Physics, 69th ed., CRC Press, Boca Raton, FL, 1988, C-161.
222. Wiencke, J. K., Pemble, S., Ketterer, B., and Kelsey, K., Gene deletion of glutathione S-transferase: correlation with induced genetic damage and potential role in endogenous mutagenesis, Cancer Epidemiol. Biomark. Prevent., 4, 253, 1995.
223. Wiencke, J. K., Christiani, D. C., and Kelsey, K. T., Bimodal distribution of sensitivity to SCE induction by diepoxybutane in human lymphocytes. I. Correlation with chromosomal aberrations, Mutat. Res., 248, 17, 1991a.
224. Wiencke, J. K., Wrensch, M. R., Miike, R., and Petrakis, N. L., Individual susceptibility to induced chromosome damage and its implications for detecting genotoxic exposures in human populations, Cancer Res., 51, 5266, 1991b.
225. Wilson, R. H., Health hazards encountered in the manufacture of synthetic rubber, JAMA, 124, 701, 1944.
226. Windholz, M., Budavari, S., Blumetti, R. F., and Otterbein, E. S., The Merck Index, Merck and Co., Rahway, NJ, 1983, 209.
227. Wiseman, R. W., Cochran, C., Dietrich, W., Lander, E. S., and Soderkvist, P., Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes, Proc. Natl. Acad. Sci. U.S.A., 91, 3759, 1994.
228. Wistuba, D., Nowotny, H.-P., Trágerf, O., and Schurig, V., Cytochrome P-450-catalyzed asymmetric epoxidation of simple prochiral and chiral aliphatic alkenes: species dependence and effect of enzyme induction on enantioselective oxirane formation, Chirality, 1, 127, 1989.
229. Xu, X. and Pang, K. S., Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver, J. Pharmacokinetics Biopharmacol., 17, 645, 1989.
230. Yamazaki, H., Guo, Z., and Guengerich, F. P., Selectivity of cytochrome P4502E1 in chlorzoxazone, Drug Metab. Dispos., 23, 438, 1995.